Navigation Links
Global Latex Conference to Showcase Vytex(TM) NRL
Date:9/26/2007

VYTEX(TM) NRL: THE NEW STANDARDIZED SOURCE MATERIAL FOR THE PRODUCTION OF

PRODUCTS USING NATURAL RUBBER LATEX(NRL)

ATLANTA, Sept. 26 /PRNewswire/ -- Rapra Technology Limited has invited Vystar Corporation to present its revolutionary Vytex(TM) NRL product at the Latex and Synthetic Polymer Dispersions Conference 2008 in Madrid in January.

"Vytex(TM) Natural Rubber Latex: A Proposed Industry Standard for the Manufacture of Commercial Natural Rubber Products" will be presented by Vystar President and Chief Operating Officer William R. Doyle.

"Vytex NRL was designed to offer a standardized source material for the production of natural rubber products," Doyle said. "We have repeatedly completed large-scale pilot production runs producing Vytex NRL that consistently meet the strictest industry standards for 'safe' NRL while retaining all the positive properties of NRL: barrier protection, elasticity, durability, stability and 'softness' for a wide range of applications. We're very excited about the opportunity to talk about Vytex NRL as the new standardized NRL source material in Madrid."

Vytex NRL is natural rubber latex that has undergone a proprietary process removing the antigenic proteins that trigger allergic reactions. Commercially available and appropriate for a wide array of applications, Vytex NRL can be integrated into many existing manufacturing environments without investment in additional equipment. In addition, when compared to traditional NRL or synthetic products, its chemical and physical properties demonstrate similar or superior performance characteristics. Vytex NRL is only slightly more expensive than traditional NRL and is competitive with many "natural rubber free" alternative materials.

The first sample batches of Vytex NRL will be shipped to the laboratories of manufacturers in industries ranging from adhesives, foams, and balloons to medical gloves, condoms and threads in fourth quarter 2007. Over the two years since Vystar first introduced Vytex NRL to Rapra 2006 conference attendees, Vytex NRL has moved into test production, been used in small runs of medical gloves, condoms and balloons, and attained consistent test scores that are backed up by quality assurance methodologies to ensure ongoing repeatability.

Vytex NRL development continues under the close scrutiny of the Vytex Technical Advisory Board of health care experts as well as that of the company's board of directors. Early in 2007, Vytex NRL earned Vystar Corporation a berth as a Top Ten Innovative Technology Company in Georgia.

About Vystar: Vystar Corporation is a privately funded corporation located in the Atlanta area. The company's operations have been focused substantially on early-stage research, development, testing and commercialization of the Vytex process. Vystar holds two U.S. patents for the Vytex(TM) technology, with additional filings pending. For more information, please visit http://www.vytex.com.

Note: Once the paper has been presented at the conference, "Vytex(TM) Natural Rubber Latex: A Proposed Industry Standard for the Manufacture of Commercial Natural Rubber Products" will be published in full on the Vytex NRL website, http://www.vytex.com.


'/>"/>
SOURCE Vystar Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Skin Cancer Research To Go Global
2. Dementia - a global problem
3. Obesity a global problem
4. Suggestions to reduce global heart disease burden
5. Drop in global deaths from measles
6. First global SARS meet opens
7. SARS-Free Taiwan to Mark End Phase of Global Fight
8. Prevent Global Warming by Becoming A Vegetarian
9. India To March Ahead in The Global HealthCare Competition
10. Global Outbreak Of Bird Flu Warning By Chinese Scientist
11. TWO India Doctors Listed in TIME for Contribution to Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the 52,404 ... has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription opioids ...
(Date:3/27/2017)... , ... March 27, 2017 , ... Harris Communications, Inc., ... hearing, is bringing its latest products to the Deaf Seniors of America Conference, April ... the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications and to ...
(Date:3/25/2017)... PA (PRWEB) , ... March 25, 2017 , ... Getting ... as a public relations partner. , All through the year, Garden Media aims ... press releases, working with key influencers and pitching client’s key messages to ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... for contaminated soil, dredged material, and hazardous and non-hazardous materials announced today the ... Pennsylvania. This acquisition will add four additional processing facilities and a vast ...
(Date:3/24/2017)... New York, NY (PRWEB) , ... March 24, ... ... cross-platform campaign: “Fighting Infection,” which will spark a conversation on the current obstacles ... decrease the number of completely preventable deaths caused by these infections. , ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
(Date:3/24/2017)... Calif. , March 24, 2017 /PRNewswire/ ... epigenetics company, and Hamilton Robotics, Inc., who ... announced an ongoing collaboration that teams Zymo ... and RNA and DNA extraction products with ... already created optimized methods for microbiomics and ...
(Date:3/24/2017)... , March 24, 2017 ... providing high-quality and cost-effective drug development and ... pharmaceutical and biotechnology industry, announced today the ... ShangPharma will be consolidating the Contract ... (CMO) under Shanghai ChemPartner. These entities include ...
Breaking Medicine Technology: